Penn Medicine 2020 Updates in Oncology
ASCO Update on MM: Does Selinexor Triplet vs. SoC Improve PFS? How to Combine Venetoclax in t(11;14) Disease? Is There a Role for Single-agent Belantamab Mafodotin?
By
Penn Medicine 2020 Updates in Oncology
FEATURING
Dan T. Vogl
By
Penn Medicine 2020 Updates in Oncology
FEATURING
Dan T. Vogl
Login to view comments.
Click here to Login